"Any modern medicine taken without prescription can be dangerous": IMA warns against misuse of weight loss drugs, seeks stronger regulation
New Delhi, March 25
The Indian Medical Association has shown concern over the use of the recently introduced GLP-1 drug for the Indian markets, and soon will be giving a memorandum to the Central government regarding its restrictive use to avoid misuse. The GLP-1 has entered the Indian market at a huge discount compared to other drugs that are already available in the country.
Speaking to ANI, the Indian Medical Association President Dr Anil Kumar J. Nayak said, "We will give a memorandum to the govt for restricting prescriptions of GLP-1 drugs to certified endocrinologists/ Diabetologists or MD general medicine to curb misuse."
He further said, "The GLP-1 drug, which was introduced for diabetic patients, is being extensively used for weight loss. This is wrong because any modern allopathic medicine taken without consulting a doctor is dangerous."
He further said, "We have told at the time of introduction of GLP-1 drugs that the medicine should be taken only under the supervision of an MD physician, diabetologist and endocrinologist, as this medicine possesses side-effects like gastric trouble, nausea, vomiting, diarrhoea, pancreatitis... This can also be fatal as there is also a rare chance of thyroid cancer."
On Tuesday, the Drug Regulator stepped up vigil on the sale of Weight Loss Drugs and intensified monitoring of the supply chain of GLP-1-based weight loss drugs amid concerns over their unauthorised sale and misuse.
The inspections were conducted at 49 entities, including online pharmacies, wholesalers, retailers & wellness clinics. Notices issued for irregularities in sales and promotions. With the patent expirations for GLP-1 drugs, used for treating type 2 diabetes and obesity, major Pharma companies released cheaper generic alternatives. These alternatives are priced at a significantly lower price than the current costs.
However, concerns have emerged regarding their on-demand availability through retail pharmacies, online platforms, wholesalers, and wellness clinics. These drugs, when used without proper medical supervision, may lead to serious adverse effects and related health risks.
— ANI
Reader Comments
Finally! The regulator is stepping in. These online pharmacies are a menace. They sell prescription drugs like candy. I hope the government brings strict rules and hefty fines for violations. Our health system is already burdened, we don't need more patients from drug misuse.
While I agree self-medication is bad, restricting it only to specialists in metros is not the full solution. What about patients in tier 2/3 cities or rural areas? There is a shortage of endocrinologists. The policy should also focus on educating all physicians.
The discount is a double-edged sword. It makes treatment affordable for genuine diabetic patients, but also makes it easily misused. The key is monitoring the supply chain, as mentioned. Wellness clinics calling it a "beauty treatment" is highly irresponsible.
Social media pressure for a "perfect" body is driving this trend. Instead of quick fixes, we need more awareness about healthy diet and exercise. These drugs have a real medical purpose and should not become a lifestyle accessory for the rich. Good move by IMA.
My aunt was prescribed this for her diabetes by a proper doctor. It helped her a lot. The problem is not the medicine, it's the people using it without prescription. The government should crack down hard on online sales. Health is not an e-commerce product.
We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.